Unveiled during Thursdays's White House Precision Medicine Initiative Summit, the New York Genome Center and IBM Watson are teaming up to create a comprehensive and open repository of genetic data to accelerate cancer research and scale access to precision medicine. Utilizing cognitive insights from IBM Watson, the partnership could help transform the way physicians deliver personalized treatment to individual patients.
Open Cancer Data Repository Details
Together, IBM and New York Genome
Read More
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Footer
